SCHEMBL5562633

SCHEMBL5562633

Nc1sc(=S)[nH]c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
IDO1 P14902 1/20 0.41
HPGD P15428 5/20 0.39
KDM4E B2RXH2 5/20 0.39
ALOX15 P16050 2/20 0.39
CYP3A4 P08684 1/20 0.39
PSMB8 P28062 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSD17B10 Q99714 4/20 0.39
GAA P10253 4/20 0.39
PLA2G10 O15496 1/20 0.39
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15946993 0.72 SMN1; SMN2 (0.40) ALDH1A1IDO1HPGDKDM4EALOX15
SCHEMBL15946994 0.69 SMN1; SMN2 (0.45) ALDH1A1IDO1HPGDKDM4EALOX15
SCHEMBL7038229 0.66 ALDH1A1 (0.56) ALDH1A1IDO1HPGDKDM4ECYP3A4
SCHEMBL15946987 0.64 ALDH1A1 (0.41) ALDH1A1IDO1HPGDKDM4EALOX15
SCHEMBL5491089 0.60 ALDH1A1 (0.58) ALDH1A1HPGDKDM4EALOX15CYP3A4
SCHEMBL21310428 0.58 HSD17B10 (0.58) ALDH1A1HPGDKDM4EALOX15CYP3A4
SCHEMBL3278733 0.58 ESR1 (0.62) ALDH1A1HPGDKDM4ETDP1HSD17B10
SCHEMBL17107090 0.57 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ECYP3A4TDP1
SCHEMBL2004652 0.57 KDM4E (0.71) ALDH1A1HPGDKDM4EHSD17B10GAA
Biphenyl SCHEMBL2574161 0.54 ALDH1A1 (0.82) ALDH1A1IDO1CYP3A4TDP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000040-B1 IL-5 INHIBITING 6-AZAURACIL DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2007-06-13 EP disclosed
US-20050090495-A1 Novel IL-5 inhibiting 6-azauracil derivatives for marking and identifying receptors and imaging organs LACRAMPE JEAN FERNAND ARMAND (FR) 2005-04-28 US disclosed
US-6867207-B2 IL-5 inhibiting 6-azauracil derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2005-03-15 US disclosed
US-20040167333-A1 Novel IL-5 inhibiting 6-azauracil derivatives for marking and identifying receptors and imaging organs LACRAMPE JEAN FERNAND ARMAND (FR) 2004-08-26 US disclosed
US-20020072603-A1 Novel IL-5 inhibiting 6-azauracil derivatives LACRAMPE JEAN FERNAND ARMAND (FR) 2002-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167333-A1 Novel IL-5 inhibiting 6-azauracil derivatives for marking and identifying receptors and imaging organs IL6ST, CXCR5, ALOX5 ALDH1A1 1219/4885IDO1 776/4885HPGD 441/4885
US-20050090495-A1 Novel IL-5 inhibiting 6-azauracil derivatives for marking and identifying receptors and imaging organs CXCR5, HCAR3, IL6ST ALDH1A1 1331/4885IDO1 944/4885HPGD 455/4885
US-20020072603-A1 Novel IL-5 inhibiting 6-azauracil derivatives IL6ST, ALOX5, IL5 ALDH1A1 848/4885IDO1 743/4885HPGD 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.